Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1425)
  3. Review (81)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3379)
  2. Solid Tumor Oncology Division (3379)
  3. GSK Faculty (1068)
  4. Department of Pathology and Laboratory Medicine (806)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (659)
  6. Human Oncology and Pathogenesis Program (633)

More Groups

People
  1. Mark Kris (870)
  2. Alexander Drilon (634)
  3. Gregory Riely (602)
  4. Charles Rudin (493)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (99)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (701)
  2. Journal of Thoracic Oncology (514)
  3. Annals of Oncology (277)
  4. Clinical Cancer Research (157)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (780)
  2. Elsevier Inc. (735)
  3. American Association for Cancer Research (385)
  4. Oxford University Press (351)
  5. Nature Publishing Group (154)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3379)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • LCMC3: Long-term disease-free and overall survival and their association with ctDNA after neoadjuvant atezolizumab for NSCLC
    Meeting Abstract

    Owen, D. H.; Chaft, J. E.; Haura, E. B.; Toloza, E.; Waqar, S. N.; Patterson, G. A.; Finley, D.; Blasberg, J.; Raz, D.; Salgia, R.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • SMARCA4 controls state plasticity in SCLC through regulation of neuroendocrine transcription factors and REST splicing
    Meeting Abstract

    Redin, E.; Sridhar, H.; Zhan, Y.; Pereira Mello, B.; Zhong, H.; Manoj, P.; Linkov, I.; Qiu, J.; Koche, R. P.; de Stanchina, E.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Targeting TROP-2 in diffuse pleural mesothelioma
    Meeting Abstract

    Offin, M. D.; Tischfield, S.; Manoj, P.; Agrawal, P.; Tendler, S.; Pratt, E. C.; Travis, W.; Rimner, A.; Simone, C. B.; de Stanchina, E.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Presenting features and diagnostic delays of NUT carcinoma: A report from the NUT Carcinoma registry
    Meeting Abstract

    Luo, J.; Walton, S. A.; Kim, J. J.; Paoloni, F.; Liew, J. W.; Cotzany, Z. Z.; Nguyen, T.; Paik, P. K.; Chaft, J. E.; Hsu, R.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Updated efficacy, safety, and biomarker analysis in patients with TRK fusion lung cancer treated with larotrectinib
    Meeting Abstract

    Lin, J. J.; Tan, D. S. W.; Kummar, S.; Moreno, V.; Leyvraz, S.; Dubashi, B.; Parambath, H.; Burcoveanu, D. I.; Neu, N.; Leserer, S.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • OncoKB: Automated somatic variant classification for rapid clinical decision making
    Meeting Abstract

    Suehnholz, S.; Nissan, M.; Zhang, H.; Kundra, R.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Cavender, K.; Preiser, B.; Konecny, J.; more...
    Journal of Molecular Diagnostics (2024)

    Fulltext@MSK | Save
  • Multi-center phase I study of concurrent paxalisib and radiation therapy in patients with solid tumor brain metastases (BM) or leptomeningeal metastases (LM) harboring PI3K pathway mutations
    Meeting Abstract

    Imber, B. S.; Kotecha, R.; Blau, M. H.; Friend, J.; Young, R. J.; Offin, M.; Michelle, R.; Diamond, E.; Yang, J. T.
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Exploratory analysis of ctDNA and imaging response in the phase I/II CHORUS study of canakinumab with chemoradiation and durvalumab consolidation for stage Ill NSCLC
    Meeting Abstract

    Shaverdian, N.; Offin, M.; Charalambous, K.; Gelblum, D.; Santini, F.; Boe, L. A.; Shepherd, A. F.; Gewanter, R. M.; Shin, J. Y.; Rimner, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • A phase I study of cyclical hypofractionated palliative radiation (Quad Shot) for lung tumors in patients with stage IV non-small cell lung cancer (NSCLC): Results from the PROMISE 006 trial
    Meeting Abstract

    Zhang, H. Y.; Iqbal, A.; Yang, J. T.; Gillespie, E. F.; Toumbacaris, N.; Zhang, Z.; Brooks, P.; Khalyat, E.; Shaverdian, N.; Gelblum, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Phase II trial of concurrent durvalumab and radiation therapy for locally advanced lung cancer
    Meeting Abstract

    Lebow, E. S.; Fitzgerald, K. J.; Shaverdian, N.; Kotecha, R.; Gomez, D. R.; Wu, A. J.; Gelblum, D.; Shepherd, A. F.; Simone, C. B. 2nd; Zhang, Z.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save